Longeveron Inc
General ticker "LGVN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $26.0M
Longeveron Inc does not follow the US Stock Market performance with the rate: -28.5%.
Estimated limits based on current volatility of 4.3%: low 1.60$, high 1.75$
Factors to consider:
- Current price 76.7% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [7.59$, 22.93$]
- 2024-12-30 to 2025-12-30 estimated range: [5.20$, 15.54$]
Financial Metrics affecting the LGVN estimates:
- Negative: Non-GAAP EPS, $ of -10.20 <= 0.10
- Negative: Operating profit margin, % of -96.74 <= 1.03
- Negative: Operating cash flow per share per price, % of -31.13 <= 2.35
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term LGVN quotes
Long-term LGVN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $1.31MM | $1.22MM | $0.71MM |
| Operating Expenses | $18.76MM | $19.27MM | $21.74MM |
| Operating Income | $-17.46MM | $-18.04MM | $-21.03MM |
| Non-Operating Income | $0.22MM | $-0.79MM | $-0.38MM |
| Interest Expense | $0.00MM | $0.00MM | $0.00MM |
| R&D Expense | $7.09MM | $9.37MM | $9.07MM |
| Income(Loss) | $-17.23MM | $-18.84MM | $-21.41MM |
| Taxes | $-0.19MM | $0.79MM | $0.00MM |
| Profit(Loss) | $-17.05MM | $-19.63MM | $-21.41MM |
| Stockholders Equity | $37.45MM | $20.50MM | $6.74MM |
| Inventory | $0.00MM | $0.62MM | $0.00MM |
| Assets | $42.77MM | $27.41MM | $12.08MM |
| Operating Cash Flow | $-9.64MM | $-13.97MM | $-19.00MM |
| Capital expenditure | $1.31MM | $0.86MM | $0.69MM |
| Investing Cash Flow | $-10.70MM | $-0.68MM | $8.19MM |
| Financing Cash Flow | $45.17MM | $-0.51MM | $5.26MM |
| Earnings Per Share* | $-9.00 | $-9.00 | $-10.22 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.